147 related articles for article (PubMed ID: 36701327)
1. High glucose promotes podocyte movement: From the perspective of single cell motility assay.
Zhang J; Zhang Y; Zhang Q; Feng Y; Deng X; Deng F; Chen B; Hu J
Cell Biol Int; 2023 Apr; 47(4):823-830. PubMed ID: 36701327
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
[TBL] [Abstract][Full Text] [Related]
4. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
7. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
[TBL] [Abstract][Full Text] [Related]
8. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
Nishad R; Mukhi D; Tahaseen SV; Mungamuri SK; Pasupulati AK
J Biol Chem; 2019 Nov; 294(44):16109-16122. PubMed ID: 31511328
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.
Su J; Li SJ; Chen ZH; Zeng CH; Zhou H; Li LS; Liu ZH
Diabetes Res Clin Pract; 2010 Feb; 87(2):167-75. PubMed ID: 19969384
[TBL] [Abstract][Full Text] [Related]
11. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
12. Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.
Tan H; Yi H; Zhao W; Ma JX; Zhang Y; Zhou X
Oncotarget; 2016 Nov; 7(45):73130-73146. PubMed ID: 27683034
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Myo1e in mouse podocytes enhances cellular endocytosis, migration, and adhesion.
Jin X; Wang W; Mao J; Shen H; Fu H; Wang X; Gu W; Liu A; Yu H; Shu Q; Du L
J Cell Biochem; 2014 Feb; 115(2):410-9. PubMed ID: 24339252
[TBL] [Abstract][Full Text] [Related]
15. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
[TBL] [Abstract][Full Text] [Related]
16. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
Dai H; Liu Q; Liu B
J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
[TBL] [Abstract][Full Text] [Related]
17. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
Zhu Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
[TBL] [Abstract][Full Text] [Related]
18. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions.
Li Z; Zhang L; Shi W; Chen Y; Zhang H; Liu S; Liang X; Ling T; Yu C; Huang Z; Tan X; Zhao X; Ye Z; Zhang B; Wang W; Li R; Ma J
Mol Med Rep; 2015 Nov; 12(5):6849-54. PubMed ID: 26352002
[TBL] [Abstract][Full Text] [Related]
20. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
